26.09.2022
|
QUESTION OF THE WEEK
GMP:Blog
Here you find current and comprehensive information about Good Manufacturing Practice. Whether mobile phone, tablet or laptop - with the GMP:Blog you stay up to date no matter where you are!
Read the information that is important to you!
This is how it works: Use the drop-down fields to filter the information type, your subject area and the year of publication. You would like to decide even faster which type of information to be displayed to you? Then simply click on the graphics!
Filter Articles:
23.09.2022
|
NEWS
EMA: Draft Quality Guidelines for Synthetic Peptides and Oligonucleotides
The European Medicines Agency (EMA) plans to establish clear quality guidelines for drug companies manufacturing synthetic peptides and oligonucleotides. This week, EMA published new concept papers, explaining current requirements on impurities testing, specifications and the control of DNA-reactive chemicals either partly or fully exclude synthetic peptides and oligonucleotides.
read more ...
23.09.2022
|
NEWS
PIC/S: Publication of Revised GMP Annex 1
The revised Annex 1 to the PIC/S GMP Guide on the manufacture of sterile products has been published and will enter into force on 25 August 2023, except for point 8.123 which is postponed until 25 August 2024. The date of entry into operation is aligned with that of the revised EU Annex 1, which is identical to PIC/S Annex 1 (with some very minor editorial differences).
read more ...
20.09.2022
|
LOGFILE Leitartikel 35/2022
Kalibrierung der Messstellen bei Pharmawasser-systemen
7 Min. Lesezeit | von Fritz Röder
Die Kalibrierung der Messstellen ist von enormer Bedeutung, denn nur mit richtigen Werten kann der Zustand der Anlage korrekt interpretiert werden. Die Kalibrierung ist auch eine grundsätzliche Vorgabe aus dem EU-GMP-Leitfaden (Punkt 3.41 EU-GMP-Leitfaden). Deshalb ist es unbedingt notwendig, die Kalibrierung von qualitätsrelevanten Messeinrichtungen genauso regelmäßig durchzuführen wie Wartungen.
read more ...
19.09.2022
|
QUESTION OF THE WEEK
Can operators of existing systems for the production of highly purified water (HPW) still refer to the Ph. Eur. now that HPW is no longer listed there?
read more ...
30.08.2022
|
LOGFILE Feature 32/2022
The new Annex 1 for the Manufacture of Sterile Medicinal Products – Focus: Barrier Systems
8 min. reading time | by Richard Denk
The first draft of version 9 of Annex 1 of the EU GMP Guide on 20 December 2017 attracted a lot of interest globally – firstly because it was the first publication on the topic in almost a decade, and secondly because PIC/S and WHO co-authored the document.
read more ...
10.06.2021
|
ASK OUR EXPERTS
Are there any requirements regarding the microbiological monitoring of sewage drains in production rooms?
Should there be a microbiological monitoring program in place specifically for the drains?
First of all, drains in production rooms are not permitted in class A/B (EU GMP Guide, Annex 1 No. 50) which means the question should refer exclusively to production rooms starting with class C. Further information on the construction of drains can be found in EU GMP Guide Part I, 3.11.
read more ...
01.09.2020
|
ASK OUR EXPERTS
Late, but not too late? How to best define the final time point of a stability study?
26.09.2022
|
QUESTION OF THE WEEK
23.09.2022
|
NEWS
PIC/S: Publication of Revised GMP Annex 1
The revised Annex 1 to the PIC/S GMP Guide on the manufacture of sterile products has been published and will enter into force on 25 August 2023, except for point 8.123 which is postponed until 25 August 2024. The date of entry into operation is aligned with that of the revised EU Annex 1, which is identical to PIC/S Annex 1 (with some very minor editorial differences).
read more ...
19.09.2022
|
QUESTION OF THE WEEK
Can operators of existing systems for the production of highly purified water (HPW) still refer to the Ph. Eur. now that HPW is no longer listed there?
read more ...
23.09.2022
|
NEWS
EMA: Draft Quality Guidelines for Synthetic Peptides and Oligonucleotides
The European Medicines Agency (EMA) plans to establish clear quality guidelines for drug companies manufacturing synthetic peptides and oligonucleotides. This week, EMA published new concept papers, explaining current requirements on impurities testing, specifications and the control of DNA-reactive chemicals either partly or fully exclude synthetic peptides and oligonucleotides.
read more ...
20.09.2022
|
LOGFILE Leitartikel 35/2022
Kalibrierung der Messstellen bei Pharmawasser-systemen
7 Min. Lesezeit | von Fritz Röder
Die Kalibrierung der Messstellen ist von enormer Bedeutung, denn nur mit richtigen Werten kann der Zustand der Anlage korrekt interpretiert werden. Die Kalibrierung ist auch eine grundsätzliche Vorgabe aus dem EU-GMP-Leitfaden (Punkt 3.41 EU-GMP-Leitfaden). Deshalb ist es unbedingt notwendig, die Kalibrierung von qualitätsrelevanten Messeinrichtungen genauso regelmäßig durchzuführen wie Wartungen.
read more ...
30.08.2022
|
LOGFILE Feature 32/2022
The new Annex 1 for the Manufacture of Sterile Medicinal Products – Focus: Barrier Systems
8 min. reading time | by Richard Denk
The first draft of version 9 of Annex 1 of the EU GMP Guide on 20 December 2017 attracted a lot of interest globally – firstly because it was the first publication on the topic in almost a decade, and secondly because PIC/S and WHO co-authored the document.
read more ...
10.06.2021
|
ASK OUR EXPERTS
Are there any requirements regarding the microbiological monitoring of sewage drains in production rooms?
Should there be a microbiological monitoring program in place specifically for the drains?
First of all, drains in production rooms are not permitted in class A/B (EU GMP Guide, Annex 1 No. 50) which means the question should refer exclusively to production rooms starting with class C. Further information on the construction of drains can be found in EU GMP Guide Part I, 3.11.
read more ...
01.09.2020
|
ASK OUR EXPERTS
Late, but not too late? How to best define the final time point of a stability study?